
Polygenic Risk Scores: A Cardiovascular Conundrum
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
Artificial intelligence models have a valuable role to play in each phase of the total testing process.
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.
Liron Pantanowitz, MD, PhD, discusses the key issues pathologists face today, and how technology could help.